Your browser doesn't support javascript.
ISTH DIC subcommittee communication on anticoagulation in COVID-19.
Thachil, Jecko; Juffermans, Nicole P; Ranucci, Marco; Connors, Jean M; Warkentin, Theodore E; Ortel, Thomas L; Levi, Marcel; Iba, Toshiaki; Levy, Jerrold H.
  • Thachil J; Department of Haematology, Manchester University Hospitals, Manchester, UK.
  • Juffermans NP; Laboratory of Experimental Intensive Care and Anesthesiology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
  • Ranucci M; Department of Intensive Care, OLVG Hospital, Amsterdam, The Netherlands.
  • Connors JM; Department of Cardiovascular Anesthesia and ICU, IRCCS Policlinico San Donato, San Donato Milanese (Milan, Italy.
  • Warkentin TE; Hematology Division, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Boston, MA, USA.
  • Ortel TL; Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada.
  • Levi M; Department of Medicine, McMaster University, Hamilton, ON, Canada.
  • Iba T; Division of Hematology, Departments of Medicine and Pathology, Duke University Medical Center, Durham, NC, USA.
  • Levy JH; Department of Medicine and Cardiometabolic Programme-NIHR UCLH/UCL BRC, University College London Hospitals NHS Foundation Trust London, London, UK.
J Thromb Haemost ; 18(9): 2138-2144, 2020 09.
Article in English | MEDLINE | ID: covidwho-641045
ABSTRACT
Hypercoagulability is an increasingly recognized complication of SARS-CoV-2 infection. As such, anticoagulation has become part and parcel of comprehensive COVID-19 management. However, several uncertainties exist in this area, including the appropriate type and dose of heparin. In addition, special patient populations, including those with high body mass index and renal impairment, require special consideration. Although the current evidence is still insufficient, we provide a pragmatic approach to anticoagulation in COVID-19, but stress the need for further trials in this area.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Blood Coagulation / Blood Coagulation Disorders / Coronavirus Infections / Betacoronavirus / Anticoagulants Type of study: Prognostic study Limits: Humans Language: English Journal: J Thromb Haemost Journal subject: Hematology Year: 2020 Document Type: Article Affiliation country: Jth.15004

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Blood Coagulation / Blood Coagulation Disorders / Coronavirus Infections / Betacoronavirus / Anticoagulants Type of study: Prognostic study Limits: Humans Language: English Journal: J Thromb Haemost Journal subject: Hematology Year: 2020 Document Type: Article Affiliation country: Jth.15004